Moderna Inc. buy BMO Capital Markets
Start price
12.01.26
/
50%
€29.02
Target price
12.01.27
-
Performance (%)
59.90%
Price
11:40
€46.40
Summary
This prediction is currently active. With a performance of 59.90% the BUY prediction by BMO_Capital_Markets is a big success. This prediction currently runs until 12.01.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 5.921% | 5.921% |
| iShares Core DAX® | 0.789% | 1.975% |
| iShares Nasdaq 100 | 4.226% | 4.344% |
| iShares Nikkei 225® | 3.285% | 6.991% |
| iShares S&P 500 | 2.496% | 2.759% |
Comments by BMO_Capital_Markets for this prediction
In the thread Moderna Inc. diskutieren
Moderna (NASDAQ:MRNA) was upgraded by analysts at BMO Capital Markets from a "market perform" rating to a "buy" rating.
Ratings data for MRNA provided by MarketBeat